PV Audit Readiness & Inspection Support Across Africa

Is Your Pharmacovigilance System Ready for Its Next Inspection?

Pharmacovigilance inspections by African regulatory authorities are becoming more frequent and rigorous. A single inspection finding can result in a warning letter, market suspension, or loss of marketing authorization. Jeyflex provides end-to-end pharmacovigilance audit and inspection support from gap assessments and mock inspections to CAPA management and ongoing audit readiness, so your system is always inspection-ready.

What are Pharmacovigilance Audits and Inspections?

Pharmacovigilance audits and inspections are systematic evaluations of a company’s pharmacovigilance system, assessing whether processes, documentation, personnel, and technology meet regulatory standards and GVP requirements. While internal audits are conducted by or on behalf of the Marketing Authorization Holder, regulatory inspections are conducted by national regulatory authorities and carry direct compliance consequences.

Both serve a critical function: identifying gaps before they become regulatory findings. The key difference is who finds them first.

Regulatory authorities conducting PV inspections across Africa evaluate:

Whether the MAH has qualified personnel, robust systems, and adequate facilities to fulfil PV obligations
Whether non-compliance exists that could jeopardise patient safety or regulatory integrity
Whether documentation, SOPs, and PV records meet the standard expected during inspection
Whether enforcement actions including suspension or licence revocation are warranted based on findings

Jeyflex helps you find and fix the gaps before the regulator does, protecting your market access and your license to operate.

Our Step-by-Step Approach to PV Audits

Every audit engagement follows a structured, documented process from initial scoping through to finding closure and ongoing readiness maintenance.

01

Gap Assessment & Audit Planning

We begin with a thorough gap assessment reviewing your existing pharmacovigilance system, SOPs, PSMF, case management processes, and documentation against current GVP requirements and the specific expectations of the regulatory authority for your market.

02

Conducting the Audit

Our experienced PV auditors conduct a systematic, evidence-based review of your pharmacovigilance system covering case management, signal detection, PSMF maintenance, PSUR compliance, literature monitoring, regulatory reporting, and staff training records.

03

Audit Reporting

A comprehensive audit report is produced, documenting all findings classified by severity (critical, major, minor), with clear references to the applicable GVP module or regulatory requirement, and specific recommendations for remediation.

04

CAPA Development & Implementation

For each finding identified, we develop a structured Corrective and Preventive Action (CAPA) plan that addresses root causes rather than surface symptoms, with defined responsibilities, timelines, and measurable effectiveness checks.

05

Follow-Up & Audit Closure

We verify that all CAPAs have been implemented effectively and that findings have been fully resolved, providing a documented audit closure confirming the system is compliant and ready for the next inspection cycle.

06

Ongoing Audit Readiness Maintenance

Inspection readiness is not a one-time exercise. We support ongoing audit readiness through scheduled internal reviews, SOP maintenance, staff awareness programs, and mock inspection exercises so your system is always prepared.

Internal Audits vs Regulatory Inspections

Understanding the difference between internal audits and regulatory inspections helps you plan your compliance programme effectively.

Internal Audits conducted by or on behalf of the MAH to proactively identify gaps, test system effectiveness, and prepare for external scrutiny. Findings stay internal and can be remediated before a regulatory visit.
Regulatory Inspections conducted by national regulatory authorities (PPB, NDA, NAFDAC, SAHPRA, etc.) to verify that the PV system meets legal obligations. Findings are formally documented and may trigger enforcement actions.
Mock Inspections a Jeyflex-led simulation of a regulatory inspection, conducted to stress-test your system before the real thing arrives. Findings are confidential and used solely to strengthen your readiness.

The best time to find a gap in your PV system is before the regulator does, during the inspection.

Why Choose Jeyflex for PV Audits and Inspections?

African Regulatory Authority Experience

Our team has direct experience of PV inspections across African markets, understanding how PPB, NDA, EFDA, RFDA, TMDA, NAFDAC, SAHPRA, and other NRAs conduct audits and what they prioritize.

Root Cause Focus

We don’t just identify findings, we investigate root causes and design CAPAs that prevent recurrence, rather than applying surface-level fixes that fail at the next inspection.

ISO 9001:2015 Certified

Our audit activities are conducted under an ISO 9001:2015 certified quality management system, ensuring consistent, documented, and independently verified processes at every stage.

Proactive Readiness, Not Reactive Recovery

We build ongoing readiness programs, not just pre-inspection scrambles. Your system stays inspection-ready continuously, not only when a regulatory visit is announced.

End-to-End Audit Support

From initial gap assessment through to CAPA closure and readiness maintenance, we manage the full audit cycle, so your team is supported at every stage, not just during the audit itself.

Staff Training & Awareness

We provide targeted training for PV teams on audit behavior, documentation standards, and inspection protocols, ensuring your staff is confident and prepared when inspectors arrive.

Our PV Audit and Inspection Services

A complete suite of audit and inspection support services covering every stage of the audit lifecycle.

Pharmacovigilance system gap assessments
Internal PV audit planning, conduct, and reporting
Mock regulatory inspection exercises
CAPA development, implementation support, and effectiveness verification
Audit findings remediation and regulatory response support
SOP review and update to address identified gaps
PSMF review and compliance verification
PV audit programme development and scheduling
Staff training and audit awareness sessions
Ongoing audit readiness maintenance programmes

The Cost of Being Unprepared for a PV Inspection

A failed or poorly performed pharmacovigilance inspection has direct consequences for your business and your patients:

Critical findings leading to immediate regulatory enforcement action
Suspension or revocation of marketing authorisation in affected markets
Reputational damage with regulatory authorities across Africa
Costly emergency remediation under regulatory scrutiny and time pressure
Patient safety risks from undetected pharmacovigilance system failures

Inspection readiness is not optional; it is a continuous obligation for every Marketing Authorisation Holder operating in Africa.

Frequently Asked Questions

A pharmacovigilance audit is conducted by or on behalf of the Marketing Authorization Holder — it is an internal quality mechanism to verify that the PV system is functioning correctly and identify gaps before a regulatory visit. A PV inspection is conducted by a national regulatory authority — it is an external examination with direct legal and regulatory consequences. Findings from a regulatory inspection may result in enforcement actions, including suspension of marketing authorisation. Jeyflex supports both — conducting internal audits to prepare you for regulatory inspections.

Yes — and the sooner you contact us, the better. When an inspection notification is received, Jeyflex conducts an immediate gap assessment, prioritises the most critical areas for remediation, supports the preparation of inspection documentation, and can conduct a mock inspection to test your team’s readiness. We have experience preparing companies for PV inspections across African regulatory authorities.

A Corrective and Preventive Action (CAPA) plan documents the root cause of each finding, the corrective actions taken to address it, the preventive actions implemented to stop recurrence, the persons responsible, implementation timelines, and how effectiveness will be verified. Jeyflex develops structured CAPA plans for every finding identified — and follows up to verify that actions have been implemented correctly and that the finding is genuinely closed, not just documented.

GVP Module I recommends that the pharmacovigilance system is audited at defined intervals — typically annually for the overall system, with additional targeted audits when significant changes occur (new products, new markets, significant process changes, or following a regulatory inspection). Jeyflex advises on the appropriate audit frequency for your specific system and risk profile, and can develop and manage an ongoing audit programme.

Yes. Jeyflex supports PV audit and inspection readiness across 16 African markets — coordinating a unified audit programme that addresses the specific regulatory requirements of each market. This is particularly valuable for companies managing products across multiple African NRAs, where inspection requirements and expectations may differ significantly between countries.

Find the Gaps Before the Regulator Does

Whether you need a gap assessment, a full internal audit, mock inspection support, or CAPA management following regulatory findings, Jeyflex is ready to help you protect your licence to operate across Africa.